Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer - Clinical Trials
The Decision to Enter a Randomized Trial of Tamoxifen for the Prevention of Breast Cancer in Healthy Women: An Analysis of the Tradeoffs
September 11th, 1995
According to the authors' abstract of an article published in American Journal of Medicine, "Objective: Interest in breast cancer prevention has led to the Breast Cancer Prevention Trial (BCPT), a controversial randomized trial of tamoxifen for women at risk for breast cancer. The goal of our study was to determine whether the potential benefits of enrolling in the randomized trial of prophylactic tamoxifen outweigh the potential risks. Methods: We used a decision analytic model based on the available data on tamoxifen treatment benefits in women with breast cancer and extrapolated to its use in healthy women. Results: For a 50-year-old woman with a breast...
Source: Women's Health Weekly (1995-09-11)
|
|
Advertisement |
|
|
